$Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan$

Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan

A 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO2 level had dropped below 95% in the supine position, he was considered as bein...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2023/06/15, Vol.62(12), pp.1765-1770
Hauptverfasser:	Katsuso, Chihiro, Kubota, Kensuke, Tanaka, Katsushi, kurita, Yusuke, Nakajima, Atsushi
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Monoclonal, Humanized Autoimmune Pancreatitis Case Report Coronaviruses Cough COVID-19 COVID19 Fever Humans Immunotherapy Internal medicine Japan Male Middle Aged Pancreatitis REGN-COV2 antibody combination therapy Remission SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!